Attempts to improve efficacy by administering anabolicagents and bisphosphonates concomitantly have been unsuccessful.
2
Clinical trials are needed to determine the long-term effectiveness and safety of novel anabolicagents for the management of osteoporosis.
3
In osteoporotic patients treated with anabolicagents, a Ca-Pi supplement appears to be preferable to carbonate or citrate Ca salt.
4
Evidence was found in the final analysis that anabolicagents were present in the supplements in sufficient amounts to cause a positive test.
5
By virtue of their secretory status, some vibe proteins may be candidates for pre-clinical development as anabolicagents for the treatment of osteoporosis.